Reponex Pharmaceuticals A/S agreed to acquire Pharma Equity Group A/S (CPSE:PEG) in Reverse Merger Transaction on April 5, 2022. 977,347,625 new shares at a nominal value of DKK 1.00 each, which will be issued to the shareholders of Reponex as consideration. OFFER IS VALID FROM APRIL 5, 2022 TILL MAY 3, 2022.

Reponex Pharmaceuticals A/S completed the acquisition of Pharma Equity Group A/S (CPSE:PEG) on March 24, 2023.